Researchers explore innovative macrocyclic peptides to target small cell lung cancer, revealing promising therapeutic strategies for this aggressive disease.
Matthew Oser, MD
Matthew Oser, MD, is an associate professor of medicine at Dana-Farber Cancer Institute and Harvard Medical School.
Articles by Matthew Oser, MD
Latest Updated Articles
New Targets Emerge for Aggressive Small Cell Lung CancerPublished: September 16th 2025 | Updated: